Literature DB >> 15167381

Advances in pharmacological treatments of IBS.

Michael Camilleri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15167381     DOI： 10.1097/00005176-200406003-00024

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  3 in total

1.  The effect of tegaserod on esophageal submucosal glands bicarbonate and mucin secretion.

Authors:  Solange Abdulnour-Nakhoul; Nelia A Tobey; Nazih L Nakhoul; Scott A Wheeler; Ximena Vanegas; Roy C Orlando
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

2.  A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.

Authors:  R G Vickery; N Mai; E Kaufman; D T Beattie; T Pulido-Rios; M O'Keefe; P P A Humphrey; J A M Smith
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

3.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.